As part of our Equality Driving Excellence Initiative, Eurofins is proud to #EmbraceEquity. We stand with International Women’s Day 2023 and imagine a gender-equal world. A world free of bias, stereotypes, and discrimination. A world that's diverse, equitable, and inclusive. A world where difference is valued and celebrated. Together we can forge women's equality. We salute our … [Read more...] about International Women’s Day
In collaboration with Eurofins Viracor Biopharma, Eurofins Central Laboratory in Shanghai, China, has expanded its respiratory syncytial virus (RSV) detection capacity since 2021 to support the rapid needs of clients for clinical research on respiratory syncytial virus (RSV). The Eurofins Central Laboratory sites in the Netherlands and Singapore have completed the installation of this … [Read more...] about Eurofins Central Laboratory China expands its offering to include RSV (respiratory syncytial virus) testing
In late March, a new wave of COVID-19 hit Shanghai, forcing the city to slow down production. In the warm spring of May, the initial results of the epidemic control were achieved, and it became a top priority for Eurofins Central Laboratory Shanghai to resume work and provide sustainable clinical support services to customers. Under the guidance of the policy and the active communication … [Read more...] about Eurofins Shanghai Central Laboratory resumed testing services on May 7, 2022
Eurofins Scientific (EUFI.PA), a global scientific leader in bioanalytical testing and clinical diagnostics testing, announces the completion of the acquisition of a majority stake in Repertoire Genesis Inc. (“RG”). RG owns a unique and proprietary analytical platform, TCR/BCR (T Cell Receptor/B Cell Receptor) repertoire profiling, that enables scientists to determine the specific … [Read more...] about Eurofins enhances its clinical and BioPharma service offering in Japan with immune repertoire analysis technology through the acquisition of Repertoire Genesis Inc.
Eurofins Technologies continues to innovate and develop a wide range of diagnostic solutions for COVID-19, particularly in response to the threat of emerging mutations. In the past days, researchers have identified a new SARS-CoV-2 variant with a concerningly high number of mutations in the spike protein. The variant was first identified in Botswana in November 2021, is spreading rapidly across … [Read more...] about Eurofins Technologies announces the launch of RT-PCR kits for the rapid detection of the fast spreading SARS-CoV-2 variant B.1.1.529
Primary Mitochondrial Myopathy (PMM) Rare diseases are one of the most challenging specialties within clinical trials, due to limited patient populations, lack of historic large scale studies to draw knowledge/clinician expertise and build upon, and frequently, lack of necessary funding to conduct thorough and multi-phased research. That is why Eurofins Central Laboratory is delighted to … [Read more...] about Primary Mitochondrial Myopathy (PMM)
Eurofins Central Laboratory is pleased to collaborate with The Emmes Company in the conduct of Diabetic Foot Osteomyelitis (DFO) clinical trials. … [Read more...] about Osteomyelitis Clinical Trials
Emmes, a leading global full-service clinical research organization (CRO), together with its rare disease CRO Orphan Reach, today announced it has signed a new five-year service agreement to extend its current relationship with Eurofins Central Laboratory. Emmes is dedicated to helping private sector, government, non-profit and academic partners achieve their biopharmaceutical development and … [Read more...] about CRO Emmes signs new five-year service agreement with Eurofins Central Laboratory
Provides significantly higher positive predictive value (PPV) and negative predictive value (NPV) than any other kidney rejection assays (or tests) on the market. Transplant Genomics (“TGI”), the transplant rejection diagnostics company committed to improving organ transplant outcomes worldwide, is pleased to introduce OmniGraf™, which combines the TruGraf® blood gene expression test … [Read more...] about Transplant Genomics Launches OmniGraf™, the Only Combination Biomarker Panel That Provides the Earliest Indication of Rejection in Kidney Transplant Recipients
Eurofins, through its empowerDX subsidiary, and Rite Aid announce the launch of an over-the-counter, FDA-authorised, at-home COVID-19 PCR Test Kit. The co-branded kits, available at all Rite Aid stores across 17 states in the USA, will offer customers a convenient way to test for the virus from their home and will detect the virus in symptomatic and asymptomatic patients. The at-home … [Read more...] about Eurofins and Rite Aid launch an over-the-counter, FDA-authorized, at-home COVID-19 PCR test in all Rite Aid locations in the U.S.